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Background: In  studies  exploring  the  effects  of HCMV  infection on  immune  system aging  (‘immunose-
nescence’),  after  organ  transplantation or  in other  settings, HCMV-specific  T-cell  responses  are often
assessed  with  respect to purportedly  ‘immunodominant’  protein subunits.  However,  the  response struc-
ture in terms of recognized antigens  and  response  hierarchies  (architecture)  is  not  well  understood  and
actual correlates  of immune protection  are not known.
Methods:  We  explored  the  distribution  of T-cell  response  sizes and  dominance  hierarchies  as  well  as
response breadth  in 33 HCMV  responders with respect to  >200  HCMV proteins.
Results:  At the  individual responder level  HCMV-specific  T-cell  responses  were  generally arranged  in clear
dominance hierarchies;  interestingly,  the number  of proteins  recognized  by  an individual correlated
closely with  the  size  of their  biggest  response.  Target-specificity varied  considerably  between  donors
and  across hierarchy  levels with  the  presence, size,  and hierarchy  position  of responses  to  purportedly
‘immunodominant’  targets being  unpredictable.
Conclusions: Predicting protective  immunity  based  on isolated  HCMV subunit-specific  T-cell  responses
is  questionable  in light  of the  complex  architecture  of the overall response.  Our  findings have important
implications  for  T-cell  monitoring,  intervention  strategies, as  well  as  the  application of animal  models  to
the  understanding  of human  infection.
© 2016 The Authors.  Published by  Elsevier Ireland  Ltd.  This  is an open  access article  under the  CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Large human CMV (HCMV)-specific T-cell responses have been
described in numerous published reports, particularly in the trans-
plantation setting and older life  (Kern et al., 2002; Ouyang et al.,
2003, 2004; Sester et al., 2002; Sylwester et al., 2005; Vescovini
et al., 2007). These conspicuous responses are  often thought to
spearhead T-cell immunity to  HCMV and many researchers believe
they grow so large because this is a  requirement for protec-
tion. Another reason, however, might be the life-long persistence
of latent HCMV infection with frequent episodes of reactivation
that gradually but steadily increase response size (Fletcher et al.,
2005; Moss, 2010). Expanded CMV-specific T-cell populations in
∗ Corresponding author at: Brighton &  Sussex Medical School, Medical Research
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humans have been modeled in the mouse using murine CMV
(MCMV) infection, where longitudinal studies have observed the
phenomenon termed memory ‘inflation’(Holtappels et al., 2000;
Lang et al., 2009; Lang and Nikolich-Zugich, 2011; O’Hara et al.,
2012; Snyder et al., 2011). ‘Inflation’ in  this context, although
not  formally defined, refers to (delayed) expansion and long-term
maintenance of specific T-cell populations after initial infection.
Interestingly, however, removal of a  highly dominant MCMV-
specific T-cell response in the BALB/c model has shown that these
responses are not  necessarily required to control infection but that
smaller responses may  take on this role even without expansion
(Holtappels et al., 2008). It still remains unclear to  what extent these
observations are applicable to humans.
Since in humans the duration of HCMV infection is  usually not
known, monitoring the development of T-cell responses beginning
at the time of infection is  not possible except in  the not entirely
compatible setting of organ transplantation (Hertoghs et al., 2010).
Numerous human studies have used cross-sectional designs using
http://dx.doi.org/10.1016/j.mad.2016.03.002
0047-6374/© 2016 The  Authors. Published by Elsevier Ireland Ltd. This is  an open access article under the CC  BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Fig. 1. CD8 T-cell immunity to  four exemplar proteins shows multiple ‘inflated’ responses (statistical outliers) across the population.
Large CD8 T-cell expansions are found with respect to  most CMV target proteins. Dotted horizontal lines indicate the upper limit above which responses are considered
outliers (upper quartile +  1.5 × inter quartile range, non-parametric definition). Note the differences in y-axis scaling in each diagram. IFN- responses are shown. The
examples illustrate considerable differences in response ‘levels’ in regards to  different proteins and different donors. Donors are shown as ‘Dx’ where x identifies identical
donors  in all figures.
different age groups to investigate changes of HCMV specific immu-
nity over time, however, this approach cannot easily distinguish the
effects of immune aging from those of the duration of HCMV infec-
tion (Alp et al., 1991; Borysiewicz et al., 1988; Fletcher et al., 2005;
Gibson et al., 2004; Khan et al., 2004; Lachmann et al., 2012; Ouyang
et al., 2003, 2004; Weekes et al., 1999). Interestingly, very large
HCMV-specific responses were described both in  older and young
populations (Komatsu et al., 2006, 2003), indicating that response
inflation is not a  direct function of chronological age.
Most human studies have investigated CD8 T-cells specific to
viral subunits, such as the HCMV UL83 (‘pp65’) and UL123 (‘IE1’)
proteins (Bunde et al., 2005; Kern et al., 1999; Lachmann et al.,
2012; Moss and Khan, 2004). Often select UL83-derived peptides
were used, such as NLVPMVATV, presented by  HLA-A*0201 or
TPRVTTTGAM, presented by  HLA-B7*0702 (Gibson et al., 2004; Khan
et al., 2004; Ouyang et al., 2003, 2004). Both peptides frequently
induce robust, sometimes exceptionally large responses, and the
high frequencies of HLA-A*0201 and HLA-B7*0702 are very conve-
nient for studies in  white American and European populations (Cao
et  al., 2001).
Despite many advances, a  breakthrough in terms of HCMV-
specific T-cell response monitoring beyond the detection of
post-transplantation immune reconstitution has not been achieved
to date (Borchers et al., 2014).  While the technological basis for
monitoring HCMV-specific T-cells has existed since roughly the mid
1990s (Altman et al., 1996; Picker et al., 1995; Waldrop et al., 1997),
correlates of protection remain undefined. This is owed largely to
the fact that we lack a  clear understanding of the structural com-
position of this response.
A study published by us in  2005 showed a surprisingly wide
spectrum of HCMV-specific T-cell target selection across a  popu-
lation sample of 33 CMV-infected healthy donors; CD8 and CD4
T-cell responses to 213 HCMV proteins were tested. This study
provided novel, fundamentally important information such as a
complete list of proteins recognized by CD8 and CD4 T-cells, the
most frequently recognized ones, and the most dominant ones (by
summated response size) (Sylwester et al., 2005). However, this
dataset contained a wealth of additional information that was not
extracted at the time of publication. In particular it was  uniquely
suited for studying the architecture of the HCMV-specific T-cell
response in  terms of the relationships between response numbers,
sizes, hierarchy levels, and target specificities, both  in individuals
and across the population. Here we present a  new, differential anal-
ysis of this dataset devised to improve our understanding of the
blueprint of this response.
Our new analysis shows that in  the vast majority of individuals
multiple T-cell responses to  HCMV are organized in  finely graded
dominance hierarchies with highly variable target specificity at
each hierarchy level. In addition there is  a  striking positive asso-
ciation between the number of recognized target proteins in  each
individual and the size of their biggest response, associating the
presence of many responses with the presence of large responses.
Despite overall structural complexity, and hugely different levels
of response size, the basic response architecture was surprisingly
similar in different individuals. This novel insight should inform the
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Table  1
Non-inflated versus inflated CMV  T-cell responses shown for proteins inducing responses in at least four donorsa and for donors responding to  at  least four proteinsa .
T-cell Subset Analysis by No.  responses analyzed No. of donors in analysis No. proteins in analysis No. of inflated responses (outliers in%)
CD8 Protein 250 33 33 26 (10.4%)
Donor 368 28 107 44 (11.9%)
CD4  Protein 230 33 20 29 (12.6%)
Donor 494 31 125 51 (10.3%)
a Minimum number of responses for applying outlier definition.
Table 2
Breakdown of inflated T-cell responses (outliersa)  by protein kinetic class, shown for proteins inducing responses in at least four donorsb and for donors responding to  at
least  four proteinsb .
Protein kinetic class Nr. of proteins with outliers Nr. of outliers Found in (Nr.  of individuals) average/max size of outliers (% of T-cells)
CD8/per protein IE 2  5 5/33 10.0/14.4
E  3  3 3/33 1.9/2.2
E-L 5  6 4/33 2.6/3.5
L  4  9 7/33 6.1/14.3
Not  assigned 4  3 3/33 3.2/4.8
CD8/per individual IE 5  14  12/28 6.4/14.4
E  3  4 4/28 2.7/6.1
E-L 5  7 7/28 2.1/3.5
L  9  15  11/28 5.0/14.3
Not  assigned 3  4 4/28 6.4/13.7
CD4/per protein IE 2  2 1/33 2.7/2.9
E  6  9 9/33 3.7/8.5
E-L 5  9 8/33 2.7/7.1
L  5  7 5/33 3.1/6.9
Not  assigned 2  2 2/33 2.3/2.8
CD4/per individual IE 3  3 3/31 1.7/2.3
E  5  16  14/31 2.9/8.5
E-L 5  10 7/31 3.9/9.6
L  6  21  14/31 2.8/7.6
Not  assigned 1  1 1/31 1.9/1.9
a Outliers were defined as values >(upper quartile + (1.5 × inter-quartile range)).
b Minimum number of responses for applying outlier definition.
measurement and interpretation HCMV-specific T-cell responses in
research and clinical settings and it should be interesting to estab-
lish if it holds true for T-cell responses to other types of antigens.
2. Materials and methods
2.1. Participants
The original study was carried out in Portland/Oregon, USA
and approved by the Institutional Review Board of Oregon Health
and Science University. The study was conducted according to the
Declaration of Helsinki; all participants gave written informed con-
sent. It included 33 CMV+ healthy individuals of various ethnic
backgrounds (white Caucasian, black African and Asian), between
19 and 53 years of age. Additional relevant details are published
(Sylwester et al., 2005).
2.2. Blood samples and activation assays
Blood samples were obtained by apheresis and anticoagulated
with sodium-heparin. PBMC were prepared according to stan-
dard protocols and cryopreserved as reported in detail elsewhere
(Sylwester et al., 2005). Briefly, thawed or fresh PBMC were incu-
bated with sets of CMV  protein-spanning peptide pools for 1 h
before addition of Brefeldin A (‘BFA’, Sigma, St. Louis, MO), then
incubated at 37C (standard incubator) for additional 5 h (final vol-
ume  of 1 ml)  in the presence of co-stimulatory antibodies, CD28
and CD49d (BD Biosciences). Following incubation, cells were har-
vested in PBS and surface stained, fixed and lysed with FACS Lysing
solution (BD Biosciences), permeabilized with BD Permeabilizing
solution (BD Biosciences), washed and stained with fluorochome-
labeled antibodies for intracellular IFN- and/or other activation
markers.
2.3. Protein selection and peptide pools
A  total of 191 ORF sequences were sourced from the AD
169 laboratory strain sequence; an additional 22 sequences were
added from the Toledo and Towne strains. Sequence data were
obtained from GenBank/EMBL/DDBJ (protein database) site  and
from the SWISS-PROT database. Consecutive 15mer peptides, over-
lapping by 10 or 11 amino acids, were synthesized for each
protein sequence using solid-phase peptide synthesis methods,
employing an Fmoc synthesis strategy (Mimotopes Pty., Ltd.). All
peptides had free acid C-termini and free amine N-termini. Peptides
associated with each CMV protein were pooled and stored in freeze-
dried aliquots at −80 ◦C. Prior to usage, freeze-dried aliquots were
dissolved in DMSO. Final peptide concentrations were 2  g/ml.
Additional details were published previously (Sylwester et al.,
2005). The assignment of protein kinetic classes was  adopted from
the historical study (Sylwester et al., 2005) and indicates the time
after viral reactivation at which certain proteins are expressed,
including immediate early (IE), early (E), early-late (EL), late (L),
and non-classified (NC) (Chambers et al., 1999).
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Fig. 2. The repertoire of targeted proteins in different individuals is  highly variable.
(A)  CD8 and CD4 T-cell responses in two  representative donors, D25 (donor 25) and D29 (donor 29) are shown. Multiple target proteins are recognized at different dominance
hierarchy levels. Note that in D25 the CD8 response is  small compared to  the CD4 response but the opposite is  true in D29. Large differences in response size between the
two  subsets were frequently observed. Columns show non log-transformed background-subtracted responses. Donors are shown as ‘Dx’ where x identifies identical donors
in  all figures. (B) Following standardization of response sizes using the Z-score calculated as Z-score (z) =  (X-)/,  where X  is  a measured value,   is  the arithmetic mean
of  all measured values, and  is  the standard deviation. The maximum Z-score (‘Max Z-score’) for each individual was plotted against their corresponding response count.
Values  outside the mean +  2 standard deviations (SD) were defined as ‘inflated responses’ or outliers with respect to individual response levels according to  our definition. The
highly significant correlation between these parameters confirms that maximum deviation from the mean is  a function of response breadth, i.e., the number of recognized
HCMV proteins in a given individual, for both CD8 and CD4 T-cells. Lines of best fit (linear) are shown in (B) and (C) and the Pearson correlation coefficient (r) is  provided
(normalized data). The  significance threshold was  set at p  <  0.05.
2.4. Flow-cytometric analysis
Data files were analyzed using the PAINT-A-GATE Plus soft-
ware program (BD Biosciences), as described previously (Sylwester
et al., 2005). Briefly, T-cell populations (CD4+ or  CD8+) were
gated from lymphocytes defined by scatter parameters, and viewed
against IFN- expression in  2D  dotplots in  order to identify posi-
tive events. Responses were expressed in  percent of the respective
reference population. Background determined from unstimulated
samples (no peptide added) was subtracted. To rule out any
spurious responses, only net CD4 responses >0.06% and net CD8
responses >0.08% were counted as positive; the algorithm used
to establish these thresholds is described in detail elsewhere
(Sylwester et al., 2005).
2.5. Statistical analysis
Tests for the normality of distribution, parametric and non-
parametric tests, and multiple regression analysis were performed
using SPSS 20.0 (IBM, Portsmouth, UK). T-cell response standardiza-
tion was performed on log-transformed data. Z-scores, also known
as standard scores (z) were calculated as z = (X-)/, where X
is  a measured value,  is  the arithmetic mean of all measured
values, and  is  the standard deviation. Definitions used for sta-
tistical outliers were as follows: (i) values greater than the upper
quartile + 1.5 ×  the inter-quartile range (non-parametric) and (ii)
values greater than the arithmetic mean +  2 standard deviations
(SD) (parametric); when using parametric definitions T-cell per-
centages were log-transformed.
3. Results
3.1. CMV  protein immunodominance is unpredictable in healthy
individuals
To begin, we sought to identify immunodominant HCMV anti-
gens that consistently generated large or very large responses in
healthy HCMV+ people. The distribution of CD8 and CD4 T-cell
responses to 213 HCMV proteins in 33 donors was visualized in
a  heat map-like format in  order to provide an overview of response
numbers, sizes, and target selection (see Supplementary Figs. S1
and S2 in  the online version at DOI: 10.1016/j.mad.2016.03.002). All
responses classified positive as per the original report (Sylwester
et al., 2005)  were used in this and subsequent analyses. The most
dominant antigens varied considerably between donors and in
regards to  kinetic class. Responses ranged from barely detectable
to double figure percentages, with the full spectrum of response
sizes often present in  the same individuals. There were no signifi-
cant gender differences with respect to the number of  recognized
target proteins or  summated responses.
Most responders recognized 5–10 CMV  proteins within each
T-cell compartment. Mapping all responses down to the level of
single peptides was beyond the scope of the study, however, in
light of our previous observation that protein-specific responses
are usually dominated by single epitopes, this would suggest that
18 A. Sylwester et al. /  Mechanisms of Ageing and Development 158 (2016) 14–22
Fig. 3. The bigger the response count the higher is  the frequency of responses representing statistical outliers.
Response counts were plotted against the Z-scores of log-transformed CD4 and CD8 T-cell responses in each individual. A positive correlation between sample size  and number
of  outliers is expected if  the response distribution is  based on  a  normal distribution. Protein kinetic classes are color-coded (IE = Immediate Early, E  = Early, E-L = Early-Late,
L  = Late, NC = not classified). Proteins of Immediate Early and Late kinetic classes appear to  be the preferred targets of CD8 T-cell response outliers, Early, Early-Late and Late
proteins  of CD4 T-cell response outliers. HCMV protein kinetic classes were assigned as previously published. Donors are shown as ‘Dx’ where x identifies identical donors
in  all figures.
responders recognize 5–10 major epitopes (Kirchner et al., 2008).
In order to address the size of these responses systematically we
first compared T-cell responses to the same protein in  different
responders, separately for CD8 and CD4 T-cells.
For CD8 T-cells this analysis was limited to 33 proteins recog-
nized by at least four responders in order to  allow the application
of statistical outlier definitions as a  working model for ‘inflated’
responses (i.e., identifying expansions outside the expected range
of responses). In this context, “inflation” is taken to represent those
responses that show an extreme phenotype among the popula-
tion.  In studies of mice, a  broader definition may  be used based on
longitudinal measurements post-infection, assessment of surface
marker expression and tissue distribution, which might include a
number of different patterns of responsiveness and a  wide range of
frequencies (Munks et al., 2006a).
CD8 T-cell responses to the same protein varied widely in  size
between donors and the threshold for calling a large response an
outlier (i.e., ‘inflated’) ranged from 0.33 to  10.57% of CD8 T-cells,
depending on the protein (Fig. 1). Such outliers accounted for 10.4%
of all responses (Table 1). We  then reversed this approach by ana-
lyzing the responses to  the proteins recognized in  each individual
(same responder, different proteins). Here, the threshold for calling
large responses outliers ranged from 0.52 to  4.82% of CD8 T-cells,
depending on the responder (28 individuals recognizing four or
more proteins were included). The proportion of outliers was in  the
same order of magnitude as in the first analysis (Table 1), but  more
importantly, the proteins recognized by the largest T-cell responses
in each responder varied considerably. This confirmed that HCMV
protein immunodominance is  not  predictable in  healthy humans,
and agrees with our  more limited, earlier finding that UL83 and
UL123 epitope immunodominance cannot be  predicted even if the
individual HLA-type is considered (Kirchner et al., 2008). The anal-
ysis of CD4 T-cell responses provided very similar results (Table 1).
The threshold for calling large CD4 T-cell responses outliers ranged
from 0.22 to 13.93% for different proteins (across all responders),
and from 0.41 to  4.31% for different responders (across the proteins
recognized by each). Additional details are provided in  Table 2.
3.2. Different individuals display similar response distributions
but different response levels
In the same individuals, the maximum response sizes of CD8
and CD4 T-cells were often very different, up  to  an order of mag-
nitude (Fig. 2A). The response levels in each T-cell compartment
were highly variable across the population. We,  therefore, stan-
dardized response size in order to  compare response distributions.
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Fig. 4. Maximum response size is  related to the number of recognized proteins.
(A) Response sizes across the whole population sample (log-transformed percentages) were standardized using the Z-score (z) = (X-)/, where X is a mea-
sured  value,  is  the arithmetic mean of all measured values, and  is the standard deviation. Z-scores were categorized (48 bins) to facilitate the visualization
of  response size distributions. Diagrams show a  large predominance of small and medium sized responses (smaller Z-scores), suggesting these responses
constitute the backbone of HCMV-specific T-cell immunity. A total of 377 Z-scores were included for CD8, and 499 Z-scores for CD4 responses. (B) Both
CD8  (left) and CD4 (right) response sums (in% of the reference subset, filled circles) correlate significantly with the  number of responses in each individual
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Z-scores were calculated for all responses in all individuals (i.e.,  for
each response its  deviation from the mean was expressed in  mul-
tiples of the SD). Interestingly, increasing response counts were
significantly associated with higher Z-scores and increasing num-
bers of outliers (i.e., Z-scores >2) (Fig. 2B). A  more detailed view of
Z-scores by protein target is  provided in  Fig. 3.  To visualize an ‘over-
all response distribution’ (i.e., at the population level) we binned
responses of similar Z-score, revealing a clear predominance of
small responses and a  sharp decline of response frequencies with
increasing response size in  both CD4 and CD8 T-cells (Fig. 4A).
To further explore an association between the number of pro-
teins recognized in each individual and absolute response size,
we considered summated and average responses (sum of all
protein-specific responses in  each individual) as well as maximum
responses. Summated response correlated significantly with the
number of recognized proteins, however, average responses were
unexpectedly similar across the donor population (Fig. 4B). At the
same time there was a  striking and significant correlation between
the number of recognized proteins in each participant and the size
of their maximum response (Fig. 4C).
Of note, the historical study identified a  subset of 15 ‘most dom-
inant’ proteins for CD8 T-cells and 6 ‘most dominant’ proteins for
CD4 T-cells, the summed response to which correlated highly with
the respective summed response to all proteins. Interestingly, the
association between the number of recognized proteins and the size
of the maximum response was preserved for these subsets of pro-
teins, albeit somewhat weaker (rs = 0.554, p =  0.001 for CD8 T-cells,
15 proteins; rs = 0.508, p =  0.003 for CD4 T-cells, 6 proteins).
3.3. HLA-type is significantly related to response levels
Because of the great differences in response levels between indi-
viduals, we explored the effect of HLA type on T-cell response
size using the available typing data (2-letter code). The number
of observations was relatively small for this type of analysis how-
ever, associations between the presence of the most frequent HLA
molecules in the cohort and summed response size were explored.
Logistic regression using stepwise inclusion of HLA types with
at least two respondents revealed that HLA-B7 was  associated
with the biggest summed responses (p <  0.001) (see Supplemen-
tary  Fig. S3 in the online version at DOI: 10.1016/j.mad.2016.03.
002). While these results should be considered preliminary because
of the small response size, the findings are in agreement with our
previous observation that individuals who were HLA-B7, HLA-B8,
or HLA-A1 positive had significantly larger responses to UL123
than individuals with none of these HLA allomorphs (Kern et al.,
2000). In addition, individuals having the following phenotypes
showed significantly greater maximum responses than the rest,
HLA-B7 (p = 0.002), HLA-B56 (p = 0.002), HLA-A1 (p = 0.006), and
HLA-A23 (p = 0.002) (not shown). Supplementary Table S1  pro-
vides an overview of summed response sizes by donor and all
HLA-allomorphs present in at least two people.
4. Discussion
Our analysis integrates individual population-based profiles of
response counts, sizes, hierarchies, and target specificities, to  cre-
ate a uniquely comprehensive picture of the structural ‘scaffold’
behind HCMV-specific T-cell immunity. Statistical outlier defini-
tions were used as an objective way to identify ‘inflated responses’
whereas the normalization of response sizes allowed us to compare
their distribution across the population despite different individual
response levels.
With many responses per individual, generally organized in
finely graded hierarchies, the response to  CMV  in humans appeared
clearly less polarized than shown in  mouse models (Munks et al.,
2006a; Northfield et al., 2005; Snyder et al., 2011). This is  probably
due to the outbred human MHC  allowing the presentation of  many
more peptides resulting in  different degrees of expansion in  paral-
lel and more than one inflated response. Response hierarchies had
a  similar architecture throughout the responder population, the
smallest response being generally just above the detection thresh-
old, irrespective of the size of the maximum response. Response
size standardization (Z-scores) allowed us to compare response
size distributions across the population, irrespective of individual
response level. The observed distribution of response sizes cor-
roborated the finding that, generally, the biggest responses are
underpinned by numerous very small, small, and medium size
responses rather than existing as isolated peaks. This fitted well
with the observation that the size of the maximum response could
be different by an order of magnitude between some but the aver-
age response size was  almost the same in  all  individuals (with many
small responses reducing the effect of very large responses on the
average). The fact that the size  of the maximum response correlated
with the number of protein-specific responses in each individual
also fits well with this explanation. Assuming that HCMV-specific
T-cell responses expand as a  function of time after infection, this
might suggest that very small responses, initially below the detec-
tion threshold, become detectable over time. However, this would
have to  be addressed in a  separate, longitudinal study.
The overall response architecture featuring a  broad base of
small and medium responses might provide robustness and flex-
ibility to the recognition of epitopes (Naumov et al., 2003) and is
more likely to  be a  guarantor of sustained, protective immunity
than the presence of isolated inflated responses. It  would be very
interesting to study if a similar response architecture is present
in T-cell responses to  other infectious agents, tumor antigens, or
self antigens, and whether there is  an association between certain
structural features and protective immunity.
Two reports by Ouyang et al. (2003, 2004) described large,
isolated, epitope-specific responses in  healthy older people and
argued that such responses might be critical for controlling HCMV
and continue to  grow bigger as a result of diminished response
‘quality’ (suggesting more of these cells are required to do the
same job) (Ouyang et al., 2003, 2004). By contrast, our analysis
shows that individuals with very large responses usually have many
additional responses, underscoring the advantage of studying mul-
tiple specificities simultaneously. The individuals studied in the
aforementioned reports were on average a  lot older than the old-
est individuals in  our  study, leaving the possibility that significant
changes might affect the TCR repertoire during older age. Never-
theless, Ouyang et al. did not look for other responses and our
own current research suggests that  many responses can be found
even in  very old  people (manuscript in preparation). It  is interesting
in this context that experiments in  BALB/c mice showed that the
most immune-dominant responses are not required for protection
(Holtappels et al., 2008).
Finally, our preliminary data with respect to MHC types
and response size argue that there is a  contribution of certain
HLA-allomorphs to  determining the magnitude of responses, con-
firming previous observations limited to UL83 and UL123 (Kern
et al., 2000). There is  limited scope for addressing this question in
(‘response count’). However, the average response size (empty circles) in each compartment (all proteins, all donors) was very similar across individuals (compare 3 B and
4). (C) The size of the biggest CD8 (left) and CD4 (right) response in each individual (‘Max. response’) also correlated significantly with the response count. Lines of best fit
(linear)  are shown in (B) and (C) and the  Spearman-Rank correlation coefficient (rs)  is  provided. The significance threshold was  set at p  <  0.05.
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inbred mouse models. On the other hand, it is known that  genetic
factors other than MHC  type contribute significantly to T-cell
response size in  MCMV  models. A comparison between C57BL/6
mice and two other strains, 129/SvJ and BALB.B (both share the hap-
lotype, H-2b, with the former but differ in their non-MHC genes)
found that all strains responded to  the same set of epitopes, but
response sizes and hierarchies differed significantly between them
(Munks et al., 2006b). Such an experiment would be difficult to  con-
duct in an outbred human or animal population and underlines a
strength of inbred mouse models.
In summary, our data demonstrates that HCMV-specific
T-cell immunity cannot be  assessed representatively by test-
ing a few, arbitrarily selected, epitope-specific responses, for
example by using single antigenic peptides for stimulation or
staining with MHC-multimers based on the presence of cer-
tain, common HLA-types. A meaningful quantitative comparison
of HCMV-specific T-cell responses between different individuals
(even if sharing one or  more HLA alleles) would clearly have to
cover many target proteins. More diverse, outbred animal models
might better reflect human diversity in future, and the measure-
ment of broader responses within such models will help dissect
the features underlying T-cell response evolution.
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